View in EDS

1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy.

Saved in:
Bibliographic Details
Title: 1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy.
Authors: Naing, A1 (AUTHOR), Autio, K A2 (AUTHOR), Falchook, G S3 (AUTHOR), Meric-Bernstam, F1 (AUTHOR), Litton, J K4 (AUTHOR), Ibrahim, N K4 (AUTHOR), Hung, A5 (AUTHOR), Oft, M6 (AUTHOR), Leveque, J7 (AUTHOR), Patel, M R8 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy288.018